.gif?ad=16248&adview=true)
![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Research Papers
Howard Hughes Medical Institute, University of California, San Francisco 94143.
Abstract
Analysis of normal mice and transgenic mice carrying a rearranged immunoglobulin mu gene revealed a more complex tissue-specific pattern of mu gene expression than anticipated from previous observations. Expression of the endogenous mu locus and the mu transgene was detected both in lymphoid tissues and in skeletal muscle. Analysis of the expression pattern of mu transgenes containing intragenic deletions or point mutations in binding sites for Oct transcription factors (OCTA sites) indicated that distinct regulatory sequences control lymphoid- and muscle-specific mu gene expression. Consistent with previous transfection experiments, mu gene expression in lymphoid tissues is dependent on the intragenic enhancer and the OCTA site in the promoter. However, neither of these regulatory sequences is required for mu gene expression in skeletal muscle that is governed by a muscle-specific control region located 3' of the enhancer. An "off-state" of the mu transgene was observed only in liver and embryonal fibroblasts, whereas enhancer-dependent mu transgene expression was detected at low levels in other nonlymphoid tissues. From these data we suggest a model for the regulation of tissue-specific mu gene expression in which a "ubiquitous" competence for basal transcription is up-regulated in lymphoid and muscle tissues by distinct cell type-specific regulatory sequences and down-regulated in liver and fibroblastic cells by putative negative sequence elements.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  B. Bartholdy, C. Du Roure, A. Bordon, D. Emslie, L. M. Corcoran, and P. Matthias The Ets factor Spi-B is a direct critical target of the coactivator OBF-1 PNAS, August 1, 2006; 103(31): 11665 - 11670. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Yuan, R. Bibi, and T. Dang The role of adjuvant on the regulatory effects of NK cells on B cell responses as revealed by a new model of NK cell deficiency Int. Immunol., May 1, 2004; 16(5): 707 - 716. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ishii, R. Sen, and M. J. Pazin Combinatorial Control of DNase I-hypersensitive Site Formation and Erasure by Immunoglobulin Heavy Chain Enhancer-binding Proteins J. Biol. Chem., February 20, 2004; 279(8): 7331 - 7338. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. E. H. Wang, D. Tantin, J. Chen, and P. A. Sharp B cell development and immunoglobulin transcription in Oct-1-deficient mice PNAS, February 17, 2004; 101(7): 2005 - 2010. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. E. H. Wang, T. Schmidt, J. Chen, P. A. Sharp, and D. Tantin Embryonic Lethality, Decreased Erythropoiesis, and Defective Octamer-Dependent Promoter Activation in Oct-1-Deficient Mice Mol. Cell. Biol., February 1, 2004; 24(3): 1022 - 1032. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. Bharadwaj, C. D. Trainor, P. Pasceri, and J. Ellis LCR-regulated transgene expression levels depend on the Oct-1 site in the AT-rich region of beta -globin intron-2 Blood, February 15, 2003; 101(4): 1603 - 1610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Andersson, J. McGuire, C. Rubio, K. Gradin, M. L. Whitelaw, S. Pettersson, A. Hanberg, and L. Poellinger A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors PNAS, July 23, 2002; 99(15): 9990 - 9995. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ren, A. Schmalstieg, D. Yuan, and R. B. Gaynor I-{kappa}B Kinase {beta} Is Critical for B Cell Proliferation and Antibody Response J. Immunol., January 15, 2002; 168(2): 577 - 587. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Theil, H. Laumen, T. Marafioti, M. Hummel, G. Lenz, T. Wirth, and H. Stein Defective octamer-dependent transcription is responsible for silenced immunoglobulin transcription in Reed-Sternberg cells Blood, May 15, 2001; 97(10): 3191 - 3196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Takahashi, S. Saito, N. Ohtani, and T. Sakai Involvement of the Oct-1 Regulatory Element of the gadd45 Promoter in the p53-independent Response to Ultraviolet Irradiation Cancer Res., February 1, 2001; 61(3): 1187 - 1195. [Abstract] [Full Text]
|
|
|
|
|
|
L. A. Fernández, M. Winkler, and R. Grosschedl Matrix Attachment Region-Dependent Function of the Immunoglobulin {micro} Enhancer Involves Histone Acetylation at a Distance without Changes in Enhancer Occupancy Mol. Cell. Biol., January 1, 2001; 21(1): 196 - 208. [Abstract] [Full Text]
|
|
|
|
|
|
H. Zhao, S. Jin, F. Fan, W. Fan, T. Tong, and Q. Zhan Activation of the Transcription Factor Oct-1 in Response to DNA Damage Cancer Res., November 1, 2000; 60(22): 6276 - 6280. [Abstract] [Full Text]
|
|
|
|
|
|
S. Stevens, J. Ong, U. Kim, L. A. Eckhardt, and R. G. Roeder Role of OCA-B in 3'-IgH Enhancer Function J. Immunol., May 15, 2000; 164(10): 5306 - 5312. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Schubart, A. Rolink, K. Schubart, and P. Matthias Cutting Edge: Lack of Peripheral B Cells and Severe Agammaglobulinemia in Mice Simultaneously Lacking Bruton's Tyrosine Kinase and the B Cell-Specific Transcriptional Coactivator OBF-1 J. Immunol., January 1, 2000; 164(1): 18 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. C. Forrester, L. A. Fernández, and R. Grosschedl Nuclear matrix attachment regions antagonize methylation-dependent repression of long-range enhancer-promoter interactions Genes & Dev., November 15, 1999; 13(22): 3003 - 3014. [Abstract] [Full Text]
|
|
|
|
|
|
C. Chauveau, E. A. Jansson, S. Muller, M. Cogne, and S. Pettersson Cutting Edge: Ig Heavy Chain 3' HS1-4 Directs Correct Spatial Position-Independent Expression of a Linked Transgene to B Lineage Cells J. Immunol., November 1, 1999; 163(9): 4637 - 4641. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Krapp and M. Strubin B-Cell Coactivator OBF-1 Exhibits Unusual Transcriptional Properties and Functions in a DNA-Bound Oct-1-Dependent Fashion Mol. Cell. Biol., June 1, 1999; 19(6): 4247 - 4254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. H. Yasui, T. Genetta, T. Kadesch, T. M. Williams, S. L. Swain, L. V. Tsui, and B. T. Huber Transcriptional Repression of the IL-2 Gene in Th Cells by ZEB J. Immunol., May 1, 1998; 160(9): 4433 - 4440. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Junker, M Lamm, V Nielsen, and P Matthias Extinction of immunoglobulin gene expression in B cells upon fusion with HeLa cells is preceded by rapid nuclear depletion of essential transcription factors and is accompanied by widespread inactivation of genes expressed in a B cell-specific manner J. Cell Sci., January 10, 1997; 110(20): 2579 - 2587. [Abstract] [PDF]
|
|
|
|
 |
|
 W. Forrester, C van Genderen, T Jenuwein, and R Grosschedl Dependence of enhancer-mediated transcription of the immunoglobulin mu gene on nuclear matrix attachment regions Science, August 26, 1994; 265(5176): 1221 - 1225. [Abstract] [PDF]
|
|
|
|
|
|
T Jenuwein, W C Forrester, R G Qiu, and R Grosschedl The immunoglobulin mu enhancer core establishes local factor access in nuclear chromatin independent of transcriptional stimulation. Genes & Dev., October 1, 1993; 7(10): 2016 - 2032. [Abstract] [PDF]
|
|
|
|
|
|
J Hagman, C Belanger, A Travis, C W Turck, and R Grosschedl Cloning and functional characterization of early B-cell factor, a regulator of lymphocyte-specific gene expression. Genes & Dev., May 1, 1993; 7(5): 760 - 773. [Abstract] [PDF]
|
|
|
|
|
|
L M Corcoran, M Karvelas, G J Nossal, Z S Ye, T Jacks, and D Baltimore Oct-2, although not required for early B-cell development, is critical for later B-cell maturation and for postnatal survival. Genes & Dev., April 1, 1993; 7(4): 570 - 582. [Abstract] [PDF]
|
|
